Alex Margolin
InvestorVenture Partner at Longwood Fund
About
Alexey (Alex) Margolin holds a Ph.D. and is a biotech entrepreneur, inventor, and scientist focused on rare and metabolic diseases. He cofounded four biotech companies—Alnara (acquired by Eli Lilly), Alcresta (acquired by Linden Partners), Allena (which went public), and Anagram Therapeutics—and has held CEO and Chairman roles. He earned undergraduate and Ph.D. degrees from Moscow University and completed postdoctoral training at MIT.
Invests in
Biotech
Investments
Board seats
AlcrestaAllenaAlnara
Investor
Anagram Therapeutics
Per the firm's website.
Colleagues at Longwood Fund
Al Sandrock
Strategic Advisory Board at Longwood Fund
Aleks Radovic-Moreno
Partner at Longwood Fund
Annalisa D'Andrea
Venture Partner at Longwood Fund
Annalisa D’Andrea
Venture Partner at Longwood Fund
Anne Klibanski
Strategic Advisory Board at Longwood Fund
Annie Vemu
Senior Associate at Longwood Fund
Aparaajita Balaji
Associate at Longwood Fund
Arielle Jackson
Head, Corporate Communications & Industry Engagement at Longwood Fund








